Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 2
1987 1
1988 4
1989 2
1990 1
1992 4
1994 1
1995 2
1996 1
1997 2
1998 1
1999 2
2001 1
2002 1
2003 4
2004 2
2005 2
2006 3
2007 1
2008 6
2009 2
2010 5
2011 4
2012 5
2013 9
2014 7
2015 6
2016 8
2017 11
2018 15
2019 11
2020 14
2021 8
2022 5
2023 10
2024 9
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

159 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of vismodegib in advanced basal-cell carcinoma.
Sekulic A, Migden MR, Oro AE, Dirix L, Lewis KD, Hainsworth JD, Solomon JA, Yoo S, Arron ST, Friedlander PA, Marmur E, Rudin CM, Chang AL, Low JA, Mackey HM, Yauch RL, Graham RA, Reddy JC, Hauschild A. Sekulic A, et al. Among authors: oro ae. N Engl J Med. 2012 Jun 7;366(23):2171-9. doi: 10.1056/NEJMoa1113713. N Engl J Med. 2012. PMID: 22670903 Free PMC article. Clinical Trial.
A scalable and cGMP-compatible autologous organotypic cell therapy for Dystrophic Epidermolysis Bullosa.
Neumayer G, Torkelson JL, Li S, McCarthy K, Zhen HH, Vangipuram M, Mader MM, Gebeyehu G, Jaouni TM, Jacków-Malinowska J, Rami A, Hansen C, Guo Z, Gaddam S, Tate KM, Pappalardo A, Li L, Chow GM, Roy KR, Nguyen TM, Tanabe K, McGrath PS, Cramer A, Bruckner A, Bilousova G, Roop D, Tang JY, Christiano A, Steinmetz LM, Wernig M, Oro AE. Neumayer G, et al. Among authors: oro ae. Nat Commun. 2024 Jul 11;15(1):5834. doi: 10.1038/s41467-024-49400-z. Nat Commun. 2024. PMID: 38992003 Free PMC article.
CCL2-mediated endothelial injury drives cardiac dysfunction in long COVID.
Thomas D, Noishiki C, Gaddam S, Wu D, Manhas A, Liu Y, Tripathi D, Kathale N, Adkar SS, Garhyan J, Liu C, Xu B, Ross EG, Dalman RL, Wang KC, Oro AE, Sallam K, Lee JT, Wu JC, Sayed N. Thomas D, et al. Among authors: oro ae. Nat Cardiovasc Res. 2024 Oct;3(10):1249-1265. doi: 10.1038/s44161-024-00543-8. Epub 2024 Oct 14. Nat Cardiovasc Res. 2024. PMID: 39402206
A scalable, GMP-compatible, autologous organotypic cell therapy for Dystrophic Epidermolysis Bullosa.
Neumayer G, Torkelson JL, Li S, McCarthy K, Zhen HH, Vangipuram M, Jackow J, Rami A, Hansen C, Guo Z, Gaddam S, Pappalardo A, Li L, Cramer A, Roy KR, Nguyen TM, Tanabe K, McGrath PS, Bruckner A, Bilousova G, Roop D, Bailey I, Tang JY, Christiano A, Steinmetz LM, Wernig M, Oro AE. Neumayer G, et al. Among authors: oro ae. bioRxiv [Preprint]. 2023 Mar 1:2023.02.28.529447. doi: 10.1101/2023.02.28.529447. bioRxiv. 2023. Update in: Nat Commun. 2024 Jul 11;15(1):5834. doi: 10.1038/s41467-024-49400-z PMID: 36909618 Free PMC article. Updated. Preprint.
Online, home-based dystrophic epidermolysis bullosa registry.
Mittal V, Nazaroff J, Eid E, Li S, Linos E, Oro A, Tang JY. Mittal V, et al. Among authors: oro a. Pediatr Dermatol. 2024 Sep-Oct;41(5):845-848. doi: 10.1111/pde.15682. Epub 2024 Jun 28. Pediatr Dermatol. 2024. PMID: 38943317
Epigenetic regulation of p63 blocks squamous-to-neuroendocrine transdifferentiation in esophageal development and malignancy.
Zhang Y, Karagiannis D, Liu H, Lin M, Fang Y, Jiang M, Chen X, Suresh S, Huang H, She J, Shi F, Liu J, Luo D, Angel JC, Lin G, Yang P, El-Rifai W, Zaika A, Oro AE, Liu K, Rustgi AK, Wang TC, Lu C, Que J. Zhang Y, et al. Among authors: oro ae. Sci Adv. 2024 Oct 11;10(41):eadq0479. doi: 10.1126/sciadv.adq0479. Epub 2024 Oct 9. Sci Adv. 2024. PMID: 39383220 Free PMC article.
LY6D marks pre-existing resistant basosquamous tumor subpopulations.
Haensel D, Gaddam S, Li NY, Gonzalez F, Patel T, Cloutier JM, Sarin KY, Tang JY, Rieger KE, Aasi SZ, Oro AE. Haensel D, et al. Among authors: oro ae. Nat Commun. 2022 Dec 6;13(1):7520. doi: 10.1038/s41467-022-35020-y. Nat Commun. 2022. PMID: 36473848 Free PMC article.
159 results